Lead Compass Investment
Lead Compass Investment is a venture capital firm based in Seongnam-si, South Korea, that focuses on both international and domestic investments in early-stage biotechnology companies. The firm specializes in identifying and supporting innovative biotech startups, aiming to foster growth and advancement in the sector. By concentrating on early-stage ventures, Lead Compass Investment seeks to capitalize on emerging opportunities within the biotechnology landscape, contributing to the development of cutting-edge solutions in healthcare and related fields.
2 past transactions
Wellmarker Bio
Series C in 2021
Wellmarker Bio focuses on developing innovative cancer drugs. Leveraging its expertise in biomarker research and R&D infrastructure from Asan Medical Center, the company aims to create new therapies that overcome drug resistance and address unmet medical needs in various cancers like colon, lung, and liver.
OxVax
Seed Round in 2021
OxVax Ltd. is a biotechnology company that originated as a spin-out from the University of Oxford. It specializes in the development of an innovative dendritic cell vaccine platform aimed at treating solid tumor cancers. The company's technology utilizes induced pluripotent stem cells (iPSC) to generate CD141+ dendritic cells, a proprietary subset known for their unique properties that enhance their potential as candidates for cancer immunotherapy. By focusing on these specialized cells, OxVax seeks to provide effective treatments for patients battling difficult-to-treat cancers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.